R. Kent McGaughy Jr., Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 164,600 shares at $19.83 ($3.3M) on 2016-06-29, disclosed to the SEC on 2016-06-30.
Open-market purchase of $3.3M RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.74 | 900 | $18K | 0.5% |
| 2 | $19.83 | 63,700 | $1.3M | 38.8% |
| 3 | $19.75 | 100,000 | $2.0M | 60.7% |
| Total | $19.78 avg | 164,600 | $3.3M | 100% |
| Filing → |
| TIL | BUY | 2021-03-25 | $9.0M | — | Filing → |
| APEN | BUY | 2020-07-21 | $2.2M | — | Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |